Fluoguide Q4 2022: Slightly shifted timelines but equity story remains unchanged - Redeye

Redeye comments on Fluoguide’s Q4 2022 report as we enter a catalyst-rich 2023e for the company. Fluoguide recently announced a slight delay in phase IIb HGG top-line data, though we judge that the company’s equity story remains unchanged following the news.

Länk till analysen i sin helhet: https://www.redeye.se/research/886606/fluoguide-q4-2022-slightly-shifted-timelines-but-equity-story-remains-unchanged?utm_source=finwire&utm_medium=RSS